Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13. (Q40073796)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13. |
scientific article |
Statements
1 reference
Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13. (English)
1 reference
Leishmania donovani
1 reference
Rajatava Basu
1 reference
Suniti Bhaumik
1 reference
Arun Kumar Haldar
1 reference
Kshudiram Naskar
1 reference
Tripti De
1 reference
Syamal Kumar Dana
1 reference
Peter Walden
1 reference
Syamal Roy
1 reference
1 October 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference